Trial intelligence / Profile preview

Prospective Study of Control of Acute Exacerbation of COPD

ChiCTR-TRC-09000301Phase 4Completed

Sponsor
The First Affiliated Hospital of Sun Yat-sen University
Start
Dec 2008
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of cortisone, budesonide, moxifloxacin, cefuroxime and azithromycin in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Health-related quality of life. Started Dec 2008; status: completed.

02

Drugs

cortisonebudesonidemoxifloxacincefuroximeazithromycin
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on ChiCTR-TRC-09000301.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-09000301.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call